Middle East & Africa Digital Pathology Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - By Product; Type ,Application, and End User

The digital pathology in Middle East & Africa is expected to grow from US$ 76.48 million in 2022 to US$ 134.25 million by 2028. It is estimated to grow at a CAGR of 9.8% from 2022 to 2028.

AI has become a part of different processes of medicine, as it offers a potential solution to managing increased workload for pathologists while delivering more consistent and timely diagnostics. It is also expected to enable pathologists to review more cases and provide accurate diagnoses in lesser than the estimated time. Technology startups are banking on the benefits of AI and deep learning methods in solving pathological problems to explore the digital pathology niche. For instance, in March 2022, Roche and Bristol Myers partnered to develop an AI-based digital pathology system to perform clinical trial assays. The partnership is intended to focus on developing two digital pathology algorithms to help with the analysis of Roche's existing clinical trial assays. Furthermore, in October 2021, PathAI, the maker of AI-enabled pathology products, Roche. The strategic partnership will entitle PathAI to develop and distribute its AI pathology technology through Roche's uPath enterprise software, which is a lab workflow platform.

Further, AI can benefit patients through its potential to lower misdiagnosis and inter-observer variability. Variations in diagnostics can result in costly and unnecessary treatments that are not useful to the patient, which may bring an expenditure burden on both patients and the healthcare system. Digital pathology tools enabled with AI can augment pathologists' decisions by supporting a more targeted, effective diagnosis and treatment.

Market Overview

Middle East & Africa is segmented into the United Arab Emirates (UAE), Saudi Arabia and South Africa, and Rest of Middle East and Africa. The market is driven by the factors such as increase in industry focus in the region, rising deployment of digital pathology solution, and growing number of conferences, meetings, workshops, and symposiums is expected to grow the digital pathology market in Middle East and Africa region. Saudi Arabia digital pathology market is growing owing to expanding healthcare industry, growing adoption of digital pathology to improve lab efficiency, and increasing demand for accurate diagnosis along with the rapid technological advancements in digital pathology systems.

Market Players in Saudi are focusing on the digital pathology market. For instance, in 2017, Sectra a medical imaging company, partnered with El Sief Development Company. The distribution agreement with El Seif includes Sectra’s Enterprise Image Management solutions, comprising PACS (Picture Archiving and Communication System) for radiology, breast imaging, pathology, and cardiology, and for sharing & collaborating around medical images. This development was aimed to strengthen Sectra’s position in the region. Furthermore, in 2015, Philips made its digital pathology solution available in Saudi Arabia. This has enabled the pathologists in the country to improve their workflow and primary diagnosis. Also, in 2018, Royal Philips, a Middle East & Africa leader in health technology teamed up with Al Borg Medical Laboratories, the largest chain of private laboratories in Saudi Arabia and the rest of the Gulf Cooperation to help reduce the time to diagnosis of cancer patients in Saudi Arabia.

Middle East & Africa Digital Pathology Market Segmentation

The Middle East & Africa digital pathology Market is segmented into product , type , application and end user.

• Based on product, the market is segmented into scanners, software, storage and communication systems. The scanners segment registered the largest market share in 2022.
• Based on type, the market is segmented into human pathology, and veterinary pathology. The human pathology segment held the larger market share in 2022.
• Based on application, the market is segmented into drug discovery, disease diagnostics, teleconsultation, and training & education. The drug discovery segment held the larger market share in 2022.
• Based on end user, the market is segmented into pharma and biotech companies, hospital, and academic. The drug discovery segment held the largest market share in 2022.
• Based on country, the market is segmented into Saudi Arabia, South Africa, UAE, and Rest of Middle East & Africa. Rest of Middle East & Africa dominated the market share in 2022. Koninklijke Philips N.V.; Nikon Corporation; PerkinElmer, Inc.; 3DHISTECH Ltd.; Hamamatsu Photonics K.K.; F.Hoffmann-La Roche Ltd; Visiopharm A/S; Glencoe Software, Inc., and; Danaher Corporation. are the leading companies operating in the digital pathology in the region.